Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Brock

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|April 5, 2021
Plasma glycerol levels in men with hypertriglyceridemiaJanne Lebeck, Birgitte Brock
Fundamental & Clinical Pharmacology|April 7, 2005
New strategies in insulin treatment: analogues and noninvasive routes of administrationJørgen Rungby, Birgitte Brock, Ole Schmitz
Ugeskrift for Laeger|September 13, 2003
[Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications]Sten Madsbad, Birgitte Brock, Ole Schmitz
Diabetes|November 25, 2004
Amylin agonists: a novel approach in the treatment of diabetesOle Schmitz, Birgitte Brock, Jorgen Rungby
Basic & Clinical Pharmacology & Toxicology|April 2, 2014
At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucoseMichael Gejl, Jørgen Rungby, Birgitte Brock, et al.
Basic & Clinical Pharmacology & Toxicology|December 1, 2004
Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potentialJesper Gromada, Birgitte Brock, Ole Schmitz, et al.
Ugeskrift for Laeger|May 30, 2006
[The place of Glitazones in the treatment of diabetes: after the PROactive study]Ole E Schmitz, Birgitte Brock, Jørgen Rungby, et al.
Expert Opinion on Pharmacotherapy|July 21, 2010
Differences between long-acting insulins for the treatment of type 2 diabetesMichael Gejl Jensen, Mikkel Hansen, Birgitte Brock, et al.
Metabolism: Clinical and Experimental|May 31, 2002
Glucose desensitization in INS-1 cells: evidence of impaired function caused by glucose metabolite(s) rather than by the glucose molecule per seBirgitte Brock, Jane H Mogensen, Søren Gregersen, et al.
Basic & Clinical Pharmacology & Toxicology|May 25, 2005
Is metformin therapy for polycystic ovary syndrome safe during pregnancy?Birgitte Brock, Kamille Smidt, Per Ovesen, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Clinical and Laboratory Investigation|April 5, 2021
Plasma glycerol levels in men with hypertriglyceridemiaJanne Lebeck, Birgitte Brock
Fundamental & Clinical Pharmacology|April 7, 2005
New strategies in insulin treatment: analogues and noninvasive routes of administrationJørgen Rungby, Birgitte Brock, Ole Schmitz
Ugeskrift for Laeger|September 13, 2003
[Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications]Sten Madsbad, Birgitte Brock, Ole Schmitz
Diabetes|November 25, 2004
Amylin agonists: a novel approach in the treatment of diabetesOle Schmitz, Birgitte Brock, Jorgen Rungby
Basic & Clinical Pharmacology & Toxicology|April 2, 2014
At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucoseMichael Gejl, Jørgen Rungby, Birgitte Brock, et al.
Basic & Clinical Pharmacology & Toxicology|December 1, 2004
Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potentialJesper Gromada, Birgitte Brock, Ole Schmitz, et al.
Ugeskrift for Laeger|May 30, 2006
[The place of Glitazones in the treatment of diabetes: after the PROactive study]Ole E Schmitz, Birgitte Brock, Jørgen Rungby, et al.
Expert Opinion on Pharmacotherapy|July 21, 2010
Differences between long-acting insulins for the treatment of type 2 diabetesMichael Gejl Jensen, Mikkel Hansen, Birgitte Brock, et al.
Metabolism: Clinical and Experimental|May 31, 2002
Glucose desensitization in INS-1 cells: evidence of impaired function caused by glucose metabolite(s) rather than by the glucose molecule per seBirgitte Brock, Jane H Mogensen, Søren Gregersen, et al.
Basic & Clinical Pharmacology & Toxicology|May 25, 2005
Is metformin therapy for polycystic ovary syndrome safe during pregnancy?Birgitte Brock, Kamille Smidt, Per Ovesen, et al.
Pageof 10